12 research outputs found
PPN5: COMPARISON OF COSTS AND COST-EFFECTIVENESS OF OXCARBAZEPINE AND SODIUM VALPROATE FOR NEW/RECENT ONSET PARTIAL SEIZURES
Get PDF
PDB16 IMPACT OF NOVOLOG EXTENDED DRUG STABILITY ON HEALTH PLAN EXPENDITURES FOR INSULIN AND SUPPLIES IN PUMP USERS
No full textPPN5: COMPARISON OF COSTS AND COST-EFFECTIVENESS OF OXCARBAZEPINE AND SODIUM VALPROATE FOR NEW/RECENT ONSET PARTIAL SEIZURES
No full textPDB19 ECONOMIC ASSESSMENT OF CONVERSION TO INSULIN PEN DEVICES IN A LONG TERM CARE FACILITY CHAIN
No full textMedicare Part D and Long-Term Care: A Systematic Review of Quantitative and Qualitative Evidence
No full text
The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review
No full textConsequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans
No full textPractice characteristics and prior authorization costs: secondary analysis of data collected by SALT-Net in 9 central New York primary care practices
No full text
